Outbreak caused by pandrug-resistant blaOXA-69/blaOXA-23/blaGES harboring Acinetobacter baumannii ST2 in an intensive care unit
Acta Microbiologica et Immunologica Hungarica · 2024
DOI: 10.1556/030.2024.02202 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Microbiologica et Immunologica Hungarica, 2024. Verfasst von Anis Raddaoui und 6 weiteren Autor:innen. Beteiligte Einrichtung: 1Laboratory Ward, National Bone Marrow Transplant Center, 1006 Tunis, Tunisia. Hauptthemen laut MEDLINE: Acinetobacter baumannii, Cross Infection. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 33 Literaturangaben.
Themen: Intensivpflege
Abstract (Originalsprache)
Acinetobacter baumannii has emerged as a main nosocomial pathogen exhibiting high rates of resistance to clinically relevant antibiotics. Six pandrug-resistant A. baumannii (PDR- A. baumannii ) were recovered from three patients in a Tunisian Intensive Care Unit (ICU) between 10th and 16th of May 2018 resulting in one fatal case and raising the possibility of an outbreak. On 18th of May environmental screening of ICU surfaces was carried out. On 22nd of May a fourth patient was infected with PDR- A. baumannii and died. A second investigation was carried out for environmental screening and PDR- A. baumannii was isolated from the respirator. Antimicrobial susceptibility testing was performed according to EUCAST (2019) guidelines. MIC of colistin was determined by broth microdilution method. PCR was used to detect 14 beta-lactamases/carbapenemases and mcr ( mcr -1 to mcr -5) genes. The genetic relatedness of PDR- A. baumannii isolates was determined by PFGE and MLST. Seven PDR- A. baumannii isolates were recovered from four patients, one MDR strain from wash basin, a PDR strain from hand sanitizer bottle and another PDR strain from respirator. All PDR- A. baumannii ( n = 9) harbored bla OXA-69 gene and none carried mcr . Moreover, seven carried bla GES and bla OXA-23 genes. PFGE identified four pulsotypes (A, B, C, and D) with the pulsotype A gathering seven PDR- A. baumannii isolates: six from three patients and one from hygiene sample. MLST revealed that all PDR- A. baumannii isolates of pulsotype A belonged to the pandemic clone ST2. Systematic screening of MDR and PDR- A. baumannii is highly recommended to limit dissemination of such strains in ICUs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- 1Laboratory Ward, National Bone Marrow Transplant Center, 1006 Tunis, Tunisia.
- 2Faculty of Medicine of Tunis, University of Tunis El Manar, LR18ES39, 1006 Tunis, Tunisia.
- 3Department of Biology, College of Science, University of Hafr Al Batin, Hafr AlBatin 31991, Saudi Arabia.
- 4Water and Food Control Lab, National Center of Salmonella, Shigella, Vibrio-Enteropathogens, Pasteur Institute of Tunis, 1007 Tunis, Tunisia.
- 5Faculty of Medicine of Tunis, Laboratory of Antibiotic Resistance LR99ES09, University of Tunis El Manar, 1006 Tunis, Tunisia.
ORCID-Profile: Mohamed Salah Abbassi
Zitieren
APA
Raddaoui, A., Mabrouk, A., Chebbi, Y., Frigui, S., Al-Gallas, N., Abbassi, M. S., & Achour, W. (2024). Outbreak caused by pandrug-resistant blaOXA-69/blaOXA-23/blaGES harboring Acinetobacter baumannii ST2 in an intensive care unit. Acta Microbiologica et Immunologica Hungarica. https://doi.org/10.1556/030.2024.02202
Vancouver
Raddaoui A, Mabrouk A, Chebbi Y, Frigui S, Al-Gallas N, Abbassi MS, et al. Outbreak caused by pandrug-resistant blaOXA-69/blaOXA-23/blaGES harboring Acinetobacter baumannii ST2 in an intensive care unit. Acta Microbiologica et Immunologica Hungarica. 2024. doi:10.1556/030.2024.02202
BibTeX
@article{Raddaoui2024,
author = {Raddaoui, Anis and Mabrouk, Aymen and Chebbi, Yosra and Frigui, Siwar and Al-Gallas, Nazek and Abbassi, Mohamed Salah and Achour, Wafa},
title = {Outbreak caused by pandrug-resistant blaOXA-69/blaOXA-23/blaGES harboring Acinetobacter baumannii ST2 in an intensive care unit},
journal = {Acta Microbiologica et Immunologica Hungarica},
year = {2024},
doi = {10.1556/030.2024.02202}
}
EUVIMED